189299-03-4
Chemical Structure
AMPK activator 6
- CAS No.: 189299-03-4
- Formula:C25H28O5
- Molecular Weight:408.49
IUPAC Name: (E)-1-(3-((Z)-3,7-dimethylocta-2,6-dien-1-yl)-2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one
InChIKey: GVXVZXDPRNGAOE-KWNFNVPNSA-N
SMILES: C/C(C)=C\CC/C(C)=C\CC1=C(C=C(C(C(/C=C/C2=CC=C(C=C2)O)=O)=C1O)O)O
Biological Activity: AMPK activator 6 (Compound GC) reduces lipid content and activates the AMPK pathway in HepG2 and 3T3-L1 cells. AMPK activator 6 significantly suppresses the increase in triglyceride (TG) , total cholesterol (TC), low-density lipoprotein-C (LDL-C), and other biochemical indices in blood serum. AMPK activator 6 can be used for the research of non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AMPK activator 6 | AMPK activator 6 (Compound GC) reduces lipid content and activates the AMPK pathway in HepG2 and 3T3-L1 cells. AMPK activator 6 significantly suppresses the increase in triglyceride (TG) , total cholesterol (TC), low-density lipoprotein-C (LDL-C), and other biochemical indices in blood serum. AMPK activator 6 can be used for the research of non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
